Making More Health Accelerator 2022
Details
One of the world’s largest networks of social entrepreneurs; Ashoka and is a world-leading, and research-driven Pharmaceutical company; Boehringer Ingelheim have collaborated to co-create and grow the global initiative – Making More Health (MMH).
Making More Health brings together the best experience in social innovation and global healthcare to improve healthcare access for people, animals, and their communities around the world. It aims to unlock the potential for growth, impact, and sustainability of promising startups in the health sector in a bid to advance access to healthcare in targeted countries across Africa.
Click: Canadian Hillman Prize 2022 (get $5000)
Phases of Making More Health
The MMH Business Accelerator is a structured business growth program that consists of 2 phases.
1. Pilot Phase
It runs for 12 months and involves co-creation and pilot implementation of a high-impact strategic project or initiative to drive growth, impact, and sustainability of participating businesses. It comes with the financial support of Euro 50,000.
2. Scale-up Phase
It also runs for 12 months and follows the successful implementation of the pilot phase. Businesses that advance to the scale-up phase receive additional financial support of between Euro 100K-200K.
Benefits of the program
- in-person and online workshops and seminars on topics about operations, systems change, replication & transfer, social finance, among others providing personal as well as professional growth.
- Engagement with BI employees may take place virtually as well as in-person through an Executive in Residence program
- Accelerator participants become part of an ever-growing and closely-knit community of ecosystem actors committed to improving health care access for humans and animals across Africa.
- Successful applicants will also be able to tap into the newly launched Making More Health access network that will potentially leverage the expert engagement and support between the social entrepreneurs and the Boehringer Ingelheim employees.
- The program provides each participant with a grant of Euros 50k for pilot implementation, with the possibility of additional scale-up funds at the end of a successful pilot.
- expert-led investment readiness coaching and support before and after the program
- a platform to showcase innovations and engage a growing community of impact investors at MMH’s annual investor showcase event as well as other external investor access events.
- Additionally, entrants into the business accelerator community will have opportunities to apply for extra funding via the just-launched Boehringer Ingelheim Social Engagement Fund.
- potential for a strategic business collaboration to be formed with the promise of significant long-term benefits for both organizations.
Eligibility criteria
- has a business or social enterprise
- the business or social enterprise should have at least three years of operation
- any sector that contributes directly or indirectly to human or animal health
- The country of operation should be Ghana, Nigeria, Kenya, Uganda and Rwanda.
- have at least USD 100,000 in annual sales revenue.
- also have evidence of social impact with clearly defined impact metrics
- In addition, three must be at least eight team members including founders and management team
- It should be one of the startups
Specifications
| Type of Opportunity | Competitions and Awards |
|---|---|
| Event Date | 26 November,2021 to 19 March,2022 |
| Deadline | 31 January,2022 |
| Open to | startups |
| Organizer | Ashoka |
| Contact the organizer | [email protected] |